Concentração alveolar mínima do isoflurano em cães tratados com duas doses de morfina by Izidoro, Karina Coelho et al.
Minimum alveolar concentration of isoflurane in dogs administered two morphine doses.
Ciência Rural, v.47, n.11, 2017.
1
Minimum alveolar concentration of isoflurane in dogs 
administered two morphine doses
Concentração  alveolar  mínima  do  isoflurano  em  cães  tratados  com  duas  doses  de  morfina
Karina  Coelho1   Eduardo  Raposo  Monteiro1, 2*   Thais  Feres  Bressan1   
Betânia  Souza  Monteiro1   Daniela  Campagnol1   Marcelo  Meller  Alievi2
ISSNe 1678-4596
Ciência Rural, Santa aria, v.47: 11, e20170132, 2017                                                        
Received 03.01.17      Approved 07.22.17      Returned by the author 09.01.17
CR-2017-0132.R2
 h tp://dx.doi.org/10.1590/0103-8478cr20170132
Morphine has been used to provide 
analgesia/antinociception in dogs (MURPHY & 
HUG, 1992; KO et al., 2009; AGUADO et al., 2011; 
MONTEIRO et al., 2016). As with other µ-opioid 
agonists, morphine decreased the minimum 
alveolar concentration (MAC) of enflurane in a 
dose-related manner in dogs (MURPHY & HUG, 
1992). Morphine also decreased the MAC of 
isoflurane (ISOMAC) in dogs, but to the authors’ 
knowledge, only studies evaluating a single dose 
of the opioid were conducted (STEFFEY et al., 
1994; KO et al., 2009). Moreover, in these previous 
studies, morphine was administered intravenously 
and only at high doses (1 to 2mg kg-1). In clinical 
practice, morphine is usually administered as 
premedication, at doses ranging from 0.1 to 1.0mg 
kg-1, by intramuscular (IM) injection.
The present study evaluated the effects 
of IM 0.5mg kg-1 (MOR0.5) and 1.0mg kg
-1 (MOR1.0) 
morphine premedication on the ISOMAC in dogs. The 
hypothesis was that morphine would decrease the 
ISOMAC in a dose-related manner.
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ABSTRACT: This study aimed to evaluate the effects of intramuscular 0.5mg kg-1 (MOR0.5) and 1.0mg kg-1 (MOR1.0) morphine premedication 
on the minimum alveolar concentration of isoflurane (ISOMAC) in dogs. Eighteen client-owned female dogs were scheduled for elective 
ovariohysterectomy. Dogs received intramuscular MOR0.5 or MOR1.0 as premedication and propofol IV for induction of anesthesia. Isoflurane 
was delivered for maintenance of anesthesia and dogs were maintained under normocapnia and normothermia. Determinations of the ISOMAC 
were conducted by use of the “up-and-down” method. Noxious stimulus (placement of Backhaus towel clamps, a midline skin incision and 
subcutaneous tissue dissection) was delivered approximately 50 minutes after premedication with MOR0.5 or MOR1.0. The calculated ISOMAC 
was 0.98±0.15% in MOR0.5 and 0.80±0.08% in MOR1.0. The ISOMAC was significantly lower in MOR1.0 compared with MOR0.5 (P=0.010). 
Results of this study suggested that intramuscular premedication with morphine 0.5 and 1.0mg kg-1 decreases the ISOMAC in a dose-related 
manner in dogs.
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RESUMO: O presente estudo objetivou avaliar os efeitos da administração intramuscular de 0,5mg kg-1 (MOR0,5) ou 1,0mg kg
-1 (MOR1,0) 
de morfina sobre a concentração alveolar mínima do isoflurano (CAM
ISO
) em cães. Dezoito cadelas de proprietários foram agendadas para 
ovário-histerectomia eletiva. As cadelas receberam MOR0,5 ou MOR1,0, como medicação pré-anestésica, e propofol IV para indução da 
anestesia. A manutenção da anestesia foi realizada com isoflurano em condições de normocapnia a normotermia. A determinação da CAM
ISO
 
foi conduzida de acordo com o método “up-and-down”. O estímulo nociceptivo (colocação de pinças Backhaus, incisão da pele na linha média 
e dissecção de tecido subcutâneo) foi realizado aproximadamente 50 minutos após a administração de MOR0,5 ou MOR1,0. A CAMISO calculada 
foi 0,98±0,15% em MOR0,5 e 0,80±0,08% em MOR1,0. A CAMISO foi significativamente menor em MOR1,0 do que em MOR0,5 (P=0,010). Os 
resultados do estudo sugerem que a medicação pré-anestésica com morfina nas doses de 0,5 e 1,0mg kg-1, pela via intramuscular, resulta em 
redução dose-dependente na CAM
ISO
 em cães.
Palavras-chave: resposta autonômica, canino, anestésicos inalatórios, opioides.
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Eighteen healthy female dogs scheduled 
for elective ovariohysterectomy (OH) were enrolled 
in the study. Any dog having clinical signs of 
systemic disease, abnormal laboratory data, or aged 
<6 months or >8 years was excluded from the study. 
The dogs were randomly administered IM 0.5mg 
kg-1 or 1.0mg kg-1 morphine (Dimorf, Cristália) as 
premedication in the MOR0.5 group and MOR1.0 
group, respectively.
Approximately 20 minutes after 
premedication, anesthesia was induced by 
administering propofol intravenously to allow 
endotracheal intubation. Dogs were positioned 
in dorsal recumbency on an electrical heating 
pad to maintain esophageal temperature between 
37oC and 38oC. Anesthesia was maintained with 
isoflurane (Isoforine, Cristália) in oxygen through 
a circle rebreathing system. Airway gases were 
sampled from between the endotracheal tube and 
the breathing system into an infrared gas analyzer 
(ILCA Sensor Module; Dräger) to monitor the 
end-tidal carbon dioxide (ETCO2) and isoflurane 
(ETiso) concentrations. A standard calibration gas 
mixture (Agent/End-Tidal CO2 Calibration Gas, 
Smiths Medical) was used to verify the calibration 
of the gas analyzer. Dogs were mechanically 
ventilated to maintain the ETCO2 between 30 and 
35mmHg. Intraoperative monitoring included heart 
rate (HR), indirect (oscillometric) systolic (SAP), 
mean (MAP) and diastolic (DAP) arterial blood 
pressures, ETCO2 and esophageal temperature 
(Lifewindow 6000Vet, Digicare). The above-
mentioned variables were registered immediately 
before the noxious stimulus was delivered.
The noxious stimulus used for ISOMAC 
determination was delivered approximately 50 
minutes after premedication with MOR0.5 or 
MOR1.0. The ISOMAC was determined by the up-
and-down method as reported in previous studies 
in dogs (AGUADO et al., 2011; MONTEIRO et al., 
2016). The ETiso for the first dog in each group 
was set at 0.8%. On all occasions, an equilibration 
period of at least 15 minutes was allowed at the 
ETiso to be tested. Thereafter, the noxious stimulus 
was delivered: placement of four Backhaus towel 
clamps, a midline skin incision and subcutaneous 
tissue dissection. A single surgeon performed the 
noxious stimuli on all occasions. The response 
to noxious stimulus was classified as positive 
or negative if the dog did or did not move the 
head, trunk, or limbs within one minute after the 
stimulus. When a positive or negative response 
was observed, the ETiso to be tested in the 
subsequent dog from the same group was increased 
or decreased by 0.1%, respectively. Observation 
of opposite responses in two consecutive dogs 
(positive followed by negative or vice-versa) was 
defined as a crossover. The ETiso concentrations 
tested in four independent crossovers were used 
to calculate the ISOMAC value in each group by 
mathematical averaging. After evaluation of the 
response to the noxious stimulus, all dogs were 
administered 0.6mg kg-1 S(+)-ketamine and 0.2mg 
kg-1 meloxicam intravenously and the ETiso was 
increased to maintain surgical depth of anesthesia 
to perform the OH. 
Data distribution was analyzed using the 
Shapiro–Wilk normality test. Differences between 
the groups in ISOMAC, HR, SAP, MAP and DAP were 
compared by unpaired t test. A Mann Whitney test 
was used to compare propofol dose and age of dogs 
between groups. For all analyzes, a P value of <0.05 
was considered significant.
Eighteen dogs completed the study (ten 
dogs in MOR0,5 and eight dogs in MOR1,0). There 
were no significant differences between the groups 
for age, weight and propofol induction dose; median 
(interquartile range) for all 18 dogs were 12 months 
(12-42 months), 11.4kg (8.4-14.1kg) and 6.1mg 
kg-1 (5.1-7.0mg kg-1), respectively. There were 
no significant differences between the groups for 
temperature and ETCO2. Mean±SD temperature 
and ETCO2 for all 18 dogs were 37.1±0.3
oC and 
32±2mmHg. Values for MAP and DAP were 
significantly lower in MOR1.0 than in MOR0.5: 
50±6mmHg versus 63±10mmHg (P=0.008); 
31±7mmHg versus 40±7mmHg (P=0.020), 
respectively. There was a trend for lower values of HR 
and SAP in MOR1.0 than in MOR0.5: 59±10beats min
-
1 versus 74±18beats min-1 (P=0.056); 79±8mmHg 
versus 93±16mmHg (P=0.051), respectively. The 
mean±SD calculated ISOMAC was 0.98±0.15% in 
MOR0.5 and 0.80±0.08% in MOR1.0 (Figure 1). The 
ISOMAC was 18% lower in MOR1.0 compared with 
MOR0.5 (P=0.010). 
In a previous study, the ISOMAC 
determined in dogs was 1.20% (MONTEIRO et al., 
2016). This previous study was performed in the 
same laboratory and using the same methodology 
of the present study. Because a control ISOMAC had 
already been determined in this previous study 
(MONTEIRO et al., 2016), we decided not to 
include a control group in the present study. In the 
study reported here, the estimated ISOMAC in the 
MOR0.5 and MOR1.0 groups is respectively 18% and 
33% lower than the 1.20% value reported in the 
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Figure 1 - Response (positive or negative) for each of the 18 anesthetized dogs at the respective end-tidal isoflurane 
concentration tested (ETiso). Before anesthetic induction with propofol, the dogs were administered 0.5mg 
kg-1 morphine (MOR0.5 group, n=10) or 1.0mg kg
-1 morphine (MOR1.0 group, n=8). (+) indicates a positive 
response; (-) indicates a negative response; shaded squares indicate the crossovers. The horizontal lines 
indicate the calculated mean ISOMAC value.
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control group by MONTEIRO et al. (2016). The 
findings of the present study are in agreement with a 
previous study that demonstrated a dose dependent 
reduction on enflurane MAC by morphine in dogs 
(MURPHY & HUG JR, 1982). 
In the present study, the noxious stimulus 
used for determination of the ISOMAC may not be 
considered a supramaximal stimulus (VALVERDE 
et al., 2003). Nevertheless, the reduction in 
the ISOMAC reported in a previous study (KO 
et al., 2009), which employed a supramaximal 
noxious stimulus for MAC determination in dogs 
administered 1.0mg kg-1 morphine IV, was nearly 
the same compared to the MOR1.0 group (34% 
versus 33%). These findings indicated that the up-
and-down method employing dogs from clinical 
practice can be a good alternative for determination 
of the MAC sparing effect of sedative or analgesic 
drugs. However, other studies need to be performed 
to support this statement.
Pure µ-opioid agonists induce vagal 
stimulation on medullary centers and decrease in HR 
(LAUBIE et al., 1979). This effect was reported to be 
dose related such that progressively increasing doses 
of alfentanil decreased HR in a dose dependent manner 
in dogs (ARNDT et al., 1986). The finding that HR 
was lower in the MOR1.0 group than in the MOR0.5 
group suggests that the higher dose of morphine 
induced a more pronounced vagal stimulation than 
the lower dose of the opioid in this study.
Based on mean values for each group, 
hypotension (MAP<60mmHg) was observed in 
MOR1.0 but not in MOR0.5. This was an unexpected 
finding as isoflurane is known to induce dose related 
cardiovascular depression in dogs (PAGEL et al., 
1991). Therefore, a higher MAP would be expected in 
MOR1.0 than in MOR0.5 because the ISOMAC was 18% 
lower in this group. The event of mild hypotension 
(MAP=50±6mmHg) in MOR1.0 might be considered 
a limitation of this study because hypotension 
decreased halothane MAC in dogs (TADIKONDA 
et al., 1981). In this previous study, the decrease in 
MAC was observed after a reduction in MAP from 
approximately 100mmHg to 60mmHg and the MAC 
was not evaluated in intermediate levels of MAP 
(TADIKONDA et al., 1981). In addition, the results 
from this previous study using halothane can not be 
extrapolated to isoflurane anesthesia. Further studies 
are necessary to evaluate the influence of different 
levels of MAP on the ISOMAC. In conclusion, results 
of this study suggest that IM premedication with 
morphine 0.5 and 1.0mg kg-1 decreases the ISOMAC 
in a dose-related manner in dogs.
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